首页> Retina (Philadelphia, Pa.)> TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN EVERYDAY PRACTICE: Identification of Health Care Constraints in Germany-The PONS Study.

TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN EVERYDAY PRACTICE: Identification of Health Care Constraints in Germany-The PONS Study.

导出原文传递

翻译打印收藏纠错

第一作者： Christoph,Ehlken

第一单位： Department of Ophthalmology, Albert-Ludwigs-University, Freiburg im Breisgau, Germany.;Department of Ophthalmology, Faculty of Medicine, Christian-Albrechts-University, Kiel, Germany.

作者： Christoph,Ehlken ^[1] ; Thomas,Wilke ^[2] ; Ulrike,Bauer-Steinhusen ^[3] ; Hansjürgen T,Agostini ^[4] ; Zoran,Hasanbasic ^[3] ; Sabrina,Müller ^[2]

作者单位： Department of Ophthalmology, Albert-Ludwigs-University, Freiburg im Breisgau, Germany.;Department of Ophthalmology, Faculty of Medicine, Christian-Albrechts-University, Kiel, Germany. ^[1] Institut für Pharmaökonomie und Arzneimittellogistik (IPAM), Wismar, Germany. ^[2] Bayer Vital GmbH, Leverkusen, Germany. ^[3] Department of Ophthalmology, Albert-Ludwigs-University, Freiburg im Breisgau, Germany. ^[4]